Smilow Cancer Hospital first in Connecticut to perform CAR T-cell therapy
One of the most promising new generations of cancer treatment called Chimeric Antigen Receptor (CAR) T-cell therapy is now available for patients at Smilow Cancer Hospital. CAR T-cell therapy is groundbreaking immunotherapy that can cure patients...
28-Mar-2019 1:05 PM EDT
Add to Favorites
Yale Cancer Center researchers combine targeted therapies to fight head and neck cancers
Yale Cancer Center researchers have identified a potential therapy that combines two types of molecularly targeted drugs to produce a synergistic effect against head and neck cancer.
19-Feb-2019 2:20 PM EST
Add to Favorites
Yale Cancer Center scientists advise caution in immunotherapy research
In a new study by Yale Cancer Center (YCC), scientists suggest that as the number of clinical trials in cancer immunotherapy grows exponentially, some caution should be exercised as we continue to better understand the biology of these new...
19-Dec-2018 12:05 PM EST
Add to Favorites
Yale Cancer Center scientists show immunotherapy drug can help patients with metastatic melanoma
When melanoma turns metastatic, it spreads to the brain in more than 40% of patients. Published today in the Journal of Clinical Oncology (JCO), a study by Yale Cancer Center researchers show a checkpoint inhibitor immunotherapy drug has meaningful...
8-Nov-2018 11:05 AM EST
Add to Favorites
Yale Cancer Center Finds Patients Choose Cancer Care Based on Hospital Affiliations
Branding matters when it comes to choosing a hospital, according to a new novel study by Yale Cancer Center (YCC) researchers published in the journal Annals of Surgical Oncology.
7-Nov-2018 9:30 AM EST
Add to Favorites
Yale Cancer Center investigators show recommended, but underused treatment for rare blood cancer saves lives
U.S. and European guidelines on treating Polycythemia Vera (PV), a potentially deadly blood cancer, call for two treatments for patients with high-risk disease: therapeutic phlebotomy and cytoreductive therapy with a drug called hydroxyurea (HU). HU...
5-Nov-2018 5:05 PM EST
Add to Favorites
Antonio Omuro named new Neuro-Oncology Chief at Yale Cancer Center
Antonio Omuro, M.D., has been appointed the new Chief of Neuro-Oncology and a Leader for the Brain Tumor Program at Yale Cancer Center (YCC) and Smilow Cancer Hospital.
5-Nov-2018 10:45 AM EST
Add to Favorites
Discovery May Help Provide Clues for Fighting and Treating HPV
Yale Cancer Center (YCC) scientists have filled in a key gap in understanding the unusual route by which the Human papillomavirus (HPV) infects cells.
15-Aug-2018 7:05 PM EDT
Add to Favorites
see all news
Five Ways to Lower Your Skin Cancer Risk
Experts at Yale Cancer Center say unless you take the right precautions, sun exposure (even if you don't get scorched) can damage your skin, causing wrinkles, age spots and even skin cancer.
22-Jun-2018 10:05 AM EDT
Yale Expert Discusses Treatment for Endometrial Cancer
Dr. Alesandro Santin Discusses Treatment for Endometrial Cancer
3-Apr-2018 3:55 PM EDT
Expert Speaks on Utilizing Information Technology to Address Oral Chemotherapy Challenges
Utilizing Information Technology to Address Oral Chemotherapy Challenges
26-Mar-2018 2:05 PM EDT
Yale Expert Available to Speak on Medical Marijuana for Children with Cancer
12-Mar-2018 3:05 PM EDT
Overcoming Resistance to Immunotherapy
For some cancer patients, the road to remission and healing can have its share of speed bumps. That’s particularly true of patients with non-small cell lung cancer (NSCLC) who develop a secondary, or acquired, resistance to immunotherapy, which...
27-Oct-2017 11:50 AM EDT
Daniel P. Petrylak, MD, on Urothelial Carcinoma: Results of the RANGE Trial
6-Oct-2017 3:05 PM EDT
Yale Expert Wins Prestigious 2017 Warren Alpert Prize
6-Oct-2017 2:05 PM EDT
Backed by Yale Cancer Center Research, FDA Approves New Immunotherapy Drug for Stomach Cancer
22-Sep-2017 4:30 PM EDT
see all experts
